Amalgamated Bank Sorrento Therapeutics, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.74 - $1.83 $8,353 - $20,658	11,289 Added 22.54%	61,373 $54,000
Q3 2022 Nov 09, 2022	BUY	$1.51 - $2.88 $218 - $417	145 Added 0.29%	50,084 $79,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $3,123 - $5,869	2,519 Added 5.31%	49,939 $100,000
Q1 2022 Jun 30, 2022	SELL	$2.0 - $4.9 $7,476 - $18,316	-3,738 Reduced 7.31%	47,420 $110,000
Q4 2021 Feb 15, 2022	BUY	$4.65 - $7.23 $13,954 - $21,697	3,001 Added 6.23%	51,158 $238,000
Q3 2021 Oct 29, 2021	SELL	$7.41 - $10.99 $15,331 - $22,738	-2,069 Reduced 4.12%	48,157 $367,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $92,659 - $145,920	14,592 Added 40.95%	50,226 $487,000
Q1 2021 May 13, 2021	SELL	$7.03 - $16.51 $23,100 - $54,251	-3,286 Reduced 8.44%	35,634 $295,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $25,822 - $53,571	4,483 Added 13.02%	38,920 $265,000
Q3 2020 Oct 30, 2020	BUY	$6.17 - $18.82 $40,351 - $123,082	6,540 Added 23.44%	34,437 $384,000
Q2 2020 Aug 10, 2020	BUY	$1.73 - $6.76 $11,097 - $43,365	6,415 Added 29.86%	27,897 $175,000
Q1 2020 May 13, 2020	BUY	$1.57 - $4.76 $1,532 - $4,645	976 Added 4.76%	21,482 $40,000
Q3 2019 Nov 13, 2019	SELL	$2.05 - $2.69 $364 - $478	-178 Reduced 0.86%	20,506 $44,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $15,128 - $24,817	5,666 Added 37.73%	20,684 $55,000
Q1 2019 May 15, 2019	BUY	$1.86 - $5.94 $1,108 - $3,540	596 Added 4.13%	15,018 $71,000
Q4 2018 Feb 15, 2019	BUY	$2.01 - $4.24 $28,988 - $61,149	14,422 New	14,422 $35,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $56,467 - $100,357	-13,381 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$4.75 - $8.0 $63,559 - $107,048	13,381 New	13,381 $96,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account